HOWL
Price
$1.52
Change
-$0.12 (-7.32%)
Updated
Dec 18, 04:17 PM (EDT)
92 days until earnings call
KRRO
Price
$45.21
Change
-$4.55 (-9.14%)
Updated
Dec 18, 04:19 PM (EDT)
Ad is loading...

HOWL vs KRRO

Header iconHOWL vs KRRO Comparison
Open Charts HOWL vs KRROBanner chart's image
Werewolf Therapeutics
Price$1.52
Change-$0.12 (-7.32%)
Volume$523
CapitalizationN/A
Korro Bio
Price$45.21
Change-$4.55 (-9.14%)
Volume$100
CapitalizationN/A
HOWL vs KRRO Comparison Chart
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. KRRO commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Hold and KRRO is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (HOWL: $1.64 vs. KRRO: $49.76)
Brand notoriety: HOWL and KRRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 32% vs. KRRO: 74%
Market capitalization -- HOWL: $73.08M vs. KRRO: $466.16M
HOWL [@Biotechnology] is valued at $73.08M. KRRO’s [@Biotechnology] market capitalization is $466.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whileKRRO’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • KRRO’s FA Score: 0 green, 5 red.
According to our system of comparison, KRRO is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 3 TA indicator(s) are bullish while KRRO’s TA Score has 7 bullish TA indicator(s).

  • HOWL’s TA Score: 3 bullish, 6 bearish.
  • KRRO’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, KRRO is a better buy in the short-term than HOWL.

Price Growth

HOWL (@Biotechnology) experienced а -11.83% price change this week, while KRRO (@Biotechnology) price change was +6.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.43%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

HOWL is expected to report earnings on Mar 20, 2025.

KRRO is expected to report earnings on Mar 27, 2024.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRRO($466M) has a higher market cap than HOWL($73.1M). KRRO YTD gains are higher at: 3.818 vs. HOWL (-57.513). HOWL has higher annual earnings (EBITDA): -55.89M vs. KRRO (-92.47M). KRRO has more cash in the bank: 137M vs. HOWL (123M). HOWL has less debt than KRRO: HOWL (36.8M) vs KRRO (41.8M). HOWL has higher revenues than KRRO: HOWL (3.39M) vs KRRO (0).
HOWLKRROHOWL / KRRO
Capitalization73.1M466M16%
EBITDA-55.89M-92.47M60%
Gain YTD-57.5133.818-1,506%
P/E RatioN/AN/A-
Revenue3.39M0-
Total Cash123M137M90%
Total Debt36.8M41.8M88%
TECHNICAL ANALYSIS
Technical Analysis
HOWLKRRO
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHAX35.250.02
+0.06%
Rydex Health Care H
MFVSX17.20N/A
N/A
MassMutual Equity Opports R5
TEMLX8.03N/A
N/A
Nuveen Emerging Markets Eq R6
TICRX22.48-0.13
-0.57%
Nuveen Large Cap Responsible Eq A
REAYX26.62-0.16
-0.60%
Russell Inv Equity Income Y

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-1.20%
GBIO - HOWL
37%
Loosely correlated
-6.03%
AURA - HOWL
35%
Loosely correlated
-2.47%
ABOS - HOWL
35%
Loosely correlated
-0.51%
ARVN - HOWL
35%
Loosely correlated
+0.58%
ATOS - HOWL
34%
Loosely correlated
-2.80%
More

KRRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRRO has been loosely correlated with PRQR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KRRO jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRRO
1D Price
Change %
KRRO100%
+3.32%
PRQR - KRRO
52%
Loosely correlated
+19.03%
WVE - KRRO
40%
Loosely correlated
+7.43%
ATNF - KRRO
37%
Loosely correlated
N/A
CDIO - KRRO
35%
Loosely correlated
-24.11%
HOWL - KRRO
33%
Poorly correlated
-1.20%
More